Cargando…
Selective enhancement of the tumour necrotic activity of TNF alpha with monoclonal antibody.
The binding and biological activity of human TNF alpha on endothelial and tumour cells has been studied in the presence of monoclonal antibodies (MAbs). In particular, one monoclonal antibody to TNF alpha (MAb 32) has been identified which failed to inhibit binding and cytotoxicity of TNF alpha on W...
Autores principales: | Rathjen, D. A., Furphy, L. J., Aston, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977761/ https://www.ncbi.nlm.nih.gov/pubmed/1377483 |
Ejemplares similares
-
Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis
por: Doki, Tomoyoshi, et al.
Publicado: (2016) -
Granulomatous inflammation in cartilage-hair hypoplasia: risks and benefits of anti-TNF alpha monoclonal antibodies
por: Moshous, D, et al.
Publicado: (2011) -
Rational Generation of Monoclonal Antibodies Selective for Pathogenic Forms of Alpha-Synuclein
por: Gibbs, Ebrima, et al.
Publicado: (2022) -
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
por: Durrant, L. G., et al.
Publicado: (1989) -
Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.
por: Kuppen, P. J., et al.
Publicado: (1997)